Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.65 |
| ▸ | HPGD | P15428 | 4/20 | 0.65 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.65 |
| ▸ | BACE1 | P56817 | 3/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HNF4A | P41235 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9236958 | 0.98 | ALDH1A1 (0.62) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL11786820 | 0.91 | ALDH1A1 (0.60) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL12023128 | 0.88 | ALDH1A1 (0.68) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL30223649 | 0.88 | ALDH1A1 (0.68) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL18150 | 0.86 | ALDH1A1 (0.65) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL8644875 | 0.86 | HDAC4 (0.50) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL8158458 | 0.86 | ALDH1A1 (0.54) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL23329593 | 0.84 | ALDH1A1 (0.62) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL12023162 | 0.84 | HPGD (0.70) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 | |
| SCHEMBL30028001 | 0.84 | ALDH1A1 (0.62) | ALDH1A1HSD17B10HPGDBCL2L1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6143379-A | Polymer laminates having increased hiding power | CLARIANT GMBH (DE) | 2000-11-07 | — | — | US | claimed |
| EP-0375287-A2 | Aromatic polymers | NORTH WEST WATER GROUP PLC (GB) | 1990-06-27 | — | — | EP | claimed |
| CN-119193074-A | Composition for forming adhesive layer, laminate, method for producing laminate, and method for treating laminate | 日铁化学材料株式会社 | 2024-12-27 | — | — | CN | disclosed |
| EP-4053095-B1 | METHOD FOR PRODUCING SODIUM SALT OF PHENOLIC COMPOUND AND BISPHOSPHITE COMPOUND | MITSUBISHI CHEM CORP (JP) | 2024-07-10 | — | — | EP | disclosed |
| EP-4053095-A1 | METHOD FOR PRODUCING SODIUM SALT OF PHENOLIC COMPOUND AND BISPHOSPHITE COMPOUND | Mitsubishi Chemical Corporation (JP) | 2022-09-07 | — | — | EP | disclosed |
| US-20220251122-A1 | METHOD FOR PRODUCING SODIUM SALT OF PHENOL COMPOUND AND BISPHOSPHITE COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-08-11 | — | — | US | disclosed |
| CN-110713588-B | Hardmask composition, hardmask layer and method of forming pattern | 三星SDI株式会社 | 2022-08-09 | — | — | CN | disclosed |
| CN-114763412-A | High-efficiency preparation method of phosphonate polymer and application of phosphonate polymer in high-temperature fuel cell | 天津师范大学 | 2022-07-19 | — | — | CN | disclosed |
| CN-114616221-A | Process for producing sodium salt of phenol compound and bisphosphite compound | 三菱化学株式会社 | 2022-06-10 | — | — | CN | disclosed |
| US-11214678-B2 | Hardmask composition, hardmask layer and method of forming patterns | SAMSUNG SDI CO., LTD. (KR) | 2022-01-04 | — | — | US | disclosed |
| CN-108368217-B | Oxazine compound, composition and cured product | DIC株式会社 | 2021-05-07 | — | — | CN | disclosed |
| US-5037936-A | Bis(acid chloride) terminated polyaryl ether ketone oligomer | AMOCO CORPORATION (US) | 1991-08-06 | — | — | US | disclosed |
| US-5011623-A | Nonlinear optical material and nonlinear optical device | CANON KABUSHIKI KAISHA (JP) | 1991-04-30 | — | — | US | disclosed |
| US-4959423-A | IMPROVED CRYSTALLIZATION RATES | AMOCO CORPORATION (US) | 1990-09-25 | — | — | US | disclosed |
| US-4910289-A | Crystal structure; blend with poly(arylene sulfide) | AMOCO CORPORATION (US) | 1990-03-20 | — | — | US | disclosed |
| EP-0351832-A2 | Nonlinear optical material and nonlinear optical device | CANON KABUSHIKI KAISHA (JP) | 1990-01-24 | — | — | EP | disclosed |
| EP-0346911-A1 | Display medium, display method and display apparatus | CANON KABUSHIKI KAISHA (JP) | 1989-12-20 | — | — | EP | disclosed |
| US-4861915-A | Poly (aryl ether ketone) block copolymers | AMOCO CORPORATION (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0292244-A2 | Polymeric liquid crystal composition and liquid crystal device | CANON KABUSHIKI KAISHA (JP) | 1988-11-23 | — | — | EP | disclosed |
| US-4786694-A | Poly(aryl ether ketone) block copolymers | AMOCO CORPORATION (US) | 1988-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251122-A1 | METHOD FOR PRODUCING SODIUM SALT OF PHENOL COMPOUND AND BISPHOSPHITE COMPOUND | SLC20A2, SOST, SLC20A1 | ALDH1A1 3616/4885HSD17B10 1554/4885HPGD 1319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.